๐Biomedical Keyword Monthly Frequency Trends
Interactive multi-year trajectory across 123,399 PubMed papers (Jan 2024 โ Sep 2026). One panel per keyword, each on its own scale. Switch between share of the month's papers and raw paper counts, filter by category, and hover a panel for monthly values.
Jan 2024 โ Sep 2026 ยท latest month may be partial
21.1%923
Jan 2024Sep 2026
15.9%558
Jan 2024Sep 2026
16.3%653
Jan 2024Sep 2026
10.9%565
Jan 2024Sep 2026
11.4%398
Jan 2024Sep 2026
9.8%434
Jan 2024Sep 2026
7.8%293
Jan 2024Sep 2026
10.8%495
Jan 2024Sep 2026
7.6%263
Jan 2024Sep 2026
7.3%360
Jan 2024Sep 2026
6.3%315
Jan 2024Sep 2026
6.3%225
Jan 2024Sep 2026
6.0%263
Jan 2024Sep 2026
7.1%271
Jan 2024Sep 2026
4.3%212
Jan 2024Sep 2026
4.3%171
Jan 2024Sep 2026
3.5%158
Jan 2024Sep 2026
3.5%182
Jan 2024Sep 2026
3.0%133
Jan 2024Sep 2026
1.9%94
Jan 2024Sep 2026
1.4%53
Jan 2024Sep 2026
0.8%36
Jan 2024Sep 2026
0.7%31
Jan 2024Sep 2026
0.6%22
Jan 2024Sep 2026
Table view
| Keyword | Category | Avg monthly share | Peak month | Matching papers |
|---|---|---|---|---|
| Prognosis & Survival Analysis | Clinical Informatics & Prognosis | 17.09% | Sep 2026 (20.92%) | 20,919 |
| Nanoparticles & Drug Delivery | Delivery & Formulation | 13.83% | Oct 2025 (15.94%) | 16,661 |
| Biomarkers & Disease Profiling | Clinical Diagnostics | 11.78% | Jul 2026 (11.6%) | 14,491 |
| Machine Learning & AI | Clinical Informatics & Prognosis | 8.46% | Jul 2026 (10.04%) | 10,500 |
| Type 2 Diabetes | Metabolic & Endocrine | 7.97% | Jan 2026 (11.37%) | 9,602 |
| Molecular Docking & SAR | Targeted Therapeutics & Chemistry | 6.97% | Sep 2026 (9.84%) | 8,509 |
| Kinase Inhibitors & Targeted Therapy | Targeted Therapeutics & Chemistry | 6.41% | Apr 2026 (6.4%) | 7,739 |
| Cancer Immunotherapy | Oncology & Immunotherapy | 6.39% | Apr 2026 (10.81%) | 7,893 |
| Obesity & Bariatric Surgery | Metabolic & Endocrine | 6.16% | Dec 2025 (7.51%) | 7,422 |
| Antimicrobial & Bioactive Agents | Infectious Disease & Pharmacology | 6.06% | Aug 2026 (6.8%) | 7,439 |
| Hydrogels & Wound Healing | Delivery & Formulation | 5.10% | Jul 2026 (5.6%) | 6,238 |
| Cardiovascular & Heart Failure | Cardiovascular & Metabolic | 5.04% | Sep 2026 (5.1%) | 6,116 |
| Pediatric Clinical Research | Healthcare & Outcomes | 4.80% | Sep 2026 (5.96%) | 5,890 |
| Surveys & Public Health | Healthcare & Outcomes | 4.13% | Jul 2026 (4.81%) | 5,092 |
| Patient Quality of Life (QoL) | Healthcare & Outcomes | 3.40% | Jul 2026 (3.77%) | 4,196 |
| Lung Cancer | Oncology & Immunotherapy | 3.33% | Jul 2026 (3.04%) | 4,064 |
| Stroke & Vascular Risk | Cardiovascular & Metabolic | 2.82% | Jul 2026 (2.81%) | 3,449 |
| Neurodegenerative & Dementia | Neurology & Aging | 2.60% | Jul 2026 (3.23%) | 3,233 |
| Colorectal Cancer | Oncology & Immunotherapy | 2.12% | Sep 2026 (3.01%) | 2,627 |
| Ferroptosis & Cell Death | Mechanisms & Cell Biology | 1.36% | Jul 2026 (1.67%) | 1,684 |
| Myocardial Infarction | Cardiovascular & Metabolic | 0.99% | Sep 2026 (1.2%) | 1,194 |
| Chemoradiotherapy | Oncology & Immunotherapy | 0.44% | Sep 2026 (0.82%) | 546 |
| Proteasome Complex | Targeted Therapeutics & Chemistry | 0.43% | Sep 2026 (0.7%) | 533 |
| Pulmonary Embolism | Cardiovascular & Metabolic | 0.39% | Sep 2025 (0.63%) | 472 |